|
|
Contents Note: These pages are, like the rest of our site, continually evolving. Non-working links will be activated shortly. Please report typos or errors to NAMA. Let’s Stop The Insanity by Anthony Scro Presidential Notes by Stan Novick The Editor’s Letter Methaphobia: Us and Them by Ira Sobel Stigma: The Invisible Barrier by Herman Joseph…
Press Release October 27, 2004 Contact: Joycelyn Woods (212) 595-6262 A Methadone Treatment Center in Alabama, “Shelby County Treatment Center” is under fire. After four trials, with no testimony or witnesses against them, a local county Judge granted a permanent injunction and says they have to stay closed. The State of Alabama that grants permission…
https://www.Methadone.org/ The premier methadone and buprenorphine patient and recovery advocacy organization in the United States. Wed, 02 Nov 2022 18:57:45 +0000 hourly 1 https://wordpress.org/?v=6.1.1
Federal Regulations & Documents Code of Federal Regulations. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule 21 CRF 291, 42 CRF 8. (Text) Federal Regulations (PDF Format) . Code of Federal Regulations. Confidentiality of Alcohol and Drug Abuse Patient Records (PDF Format). CSAT Accreditation Page. CSAT Guidelines for the accreditation of…
Over the years methadone providers and patients have begun using client in place of patient. While this maybe well intended NAMA is concerned that the results could become damaging to methadone treatment, and most especially to patients. The use of client is deprogating to methadone patients, inferring that their addiction to narcotics is their fault…
FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…
